Cargando…

Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients

Treatment of severe acute respiratory syndrome (SARS) is experimental, and the effectiveness of ribavirin–steroid therapy is unclear. Forty SARS patients with progressive disease after ribavirin treatment and 1.5 g of pulsed methylprednisolone were given either convalescent plasma (n = 19) or furthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soo, Y. O. Y., Cheng, Y., Wong, R., Hui, D. S., Lee, C. K., Tsang, K. K. S., Ng, M. H. L., Chan, P., Cheng, G., Sung, J. J. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Science Ltd 2004
Materias:	Research Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129386/ https://www.ncbi.nlm.nih.gov/pubmed/15214887 http://dx.doi.org/10.1111/j.1469-0691.2004.00956.x

Ejemplares similares

Use of convalescent plasma therapy in SARS patients in Hong Kong
por: Cheng, Y., et al.
Publicado: (2004)

A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
por: Bidin, F.N., et al.
Publicado: (2023)

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity
por: Nomoto, Hidetoshi, et al.
Publicado: (2021)

Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
por: Park, E. A., et al.
Publicado: (2001)

Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents
por: Tsang, Hing Wai, et al.
Publicado: (2021)

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome
por: Heyman, Benjamin M., et al.
Publicado: (2022)

Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
por: Jin, Changzhong, et al.
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/enoxaparin-sodium/methylprednisolone: Various toxicities and off label use: case report
Publicado: (2021)

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Treatment of postoperative lung injury in patients with SIRS by methylprednisolone
por: Sumida, M, et al.
Publicado: (1998)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

Use of convalescent plasma therapy in eight individuals with mild COVID-19
por: Ji, F., et al.
Publicado: (2020)

Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia
por: Castro, J E, et al.
Publicado: (2014)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
por: Wong, Ngai Sze, et al.
Publicado: (2022)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: De Santis, Gil C., et al.
Publicado: (2022)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

The Management of Convalescence
Publicado: (1907)

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
por: Holm, Karin, et al.
Publicado: (2021)

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
por: Lee, Nelson, et al.
Publicado: (2004)

Evidence-based dosing of convalescent plasma for COVID-19 in future trials
por: Rijnders, Bart J.A., et al.
Publicado: (2022)

COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors
por: Ragnesola, Brett, et al.
Publicado: (2020)

Towards characterized convalescent plasma for COVID-19: The dose matters
por: Verkerke, Hans P., et al.
Publicado: (2020)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Effectiveness of convalescent plasma in Indian patients with COVID-19
por: Budhiraja, Sandeep, et al.
Publicado: (2021)

Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone
por: Qin, L., et al.
Publicado: (2006)

COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
por: Bansal, N., et al.
Publicado: (2022)

Childhood COVID-19: a multicentre retrospective study
por: Chen, Z., et al.
Publicado: (2020)

Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report
por: Bayrak, Muharrem, et al.
Publicado: (2021)

The effect of pre-operative high doses of methylprednisolone on pain management and convalescence after total hip replacement in elderly: a double-blind randomized study
por: Gądek, Artur, et al.
Publicado: (2020)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response)
por: De Santis, Gil C., et al.
Publicado: (2022)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

Protective effect of methylprednisolone on ventilator-induced diaphragm dysfunction is dose dependent
por: Maes, K, et al.
Publicado: (2010)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Taking cues from convalescence to improve vaccines against hepatitis C virus
por: Sreekumar, Bharath K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j1j2eofcptmgpdop4q6tfi6dpd